E-mail a Wiley Online Library Link

Alfredo Alberti Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B? Hepatology 38

Article first published online: 30 DEC 2003 | DOI: 10.1053/jhep.2003.50280

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field